Sodium-glucose cotransporter-2 inhibitors to stABiLizE coronary atherosclerosis pro-gression after acute Myocardial Infarction in women and men with diabetes mellitus
Latest Information Update: 19 Feb 2026
At a glance
- Drugs Canagliflozin (Primary) ; Dapagliflozin (Primary) ; Empagliflozin (Primary)
- Indications Cardiovascular disorders; Coronary arteriosclerosis
- Focus Therapeutic Use
Most Recent Events
- 19 Feb 2026 New trial record